| Title : Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease - Bateman_2022_Alzheimers.Res.Ther_14_178 |
| Author(s) : Bateman RJ , Cummings J , Schobel S , Salloway S , Vellas B , Boada M , Black SE , Blennow K , Fontoura P , Klein G , Assuncao SS , Smith J , Doody RS |
| Ref : Alzheimers Res Ther , 14 :178 , 2022 |
| Abstract : Bateman_2022_Alzheimers.Res.Ther_14_178 |
| ESTHER : Bateman_2022_Alzheimers.Res.Ther_14_178 |
| PubMedSearch : Bateman_2022_Alzheimers.Res.Ther_14_178 |
| PubMedID: 36447240 |
Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, Black SE, Blennow K, Fontoura P, Klein G, Assuncao SS, Smith J, Doody RS (2022)
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease
Alzheimers Res Ther
14 :178
Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, Black SE, Blennow K, Fontoura P, Klein G, Assuncao SS, Smith J, Doody RS (2022)
Alzheimers Res Ther
14 :178